Tuberculosis & HIV Co-Infection Training Program in Kenya

结核

基本信息

  • 批准号:
    10596477
  • 负责人:
  • 金额:
    $ 28.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Abstract Tuberculosis (TB) is the leading cause of death in people living with HIV infection (PLHIV). Despite the discovery of Mycobacterium tuberculosis (Mtb) over 100 years ago and the availability of effective drugs for over 60 years, there remain formidable hurdles for controlling TB including the lack of a highly efficacious vaccine, long drug treatment regimens, prevention of infection, and killing dormant bacilli within macrophages. To address these problems, novel research and public health strategies need to be developed and coupled with enhanced training and local capacity building in high TB endemic countries. Kenya is one of 30 TB high burden countries which together constitute over 80% of global TB cases. The University of Nairobi (UoN), the Kenya Medical Research Institute (KEMRI) and the University of Washington (UW) propose a new TB-HIV Training Program (TBHTP) to address these needs. The TBHTP includes close partnerships in Kenya with the Ministry of Health National Tuberculosis Leprosy and Lung Disease Program (MoH NTLP), and the Kenya Pediatric Research Consortium (KEPRECON) – the research organization affiliated with the Kenya Pediatric Association (KPA). The primary goal of our program is to collaboratively develop training opportunities to address local needs in training and research capacity building. This partnership builds on a 35- year history of collaboration and training in HIV research between UW, KEMRI, and UoN. Although this partnership has been highly successful, TB has not been a high priority or focused goal of previous efforts. To build the capacity of KEMRI and the University of Nairobi (UoN) to conduct TB and TB-HIV co-infection research, we propose to implement a long-term training degree-earning track, a medium-term training non- degree track, and a short-term training track. During the 5-year period, we will train 5 UW MPH, 5 UoN Fellowship in Epidemiology, and 5 UoN PhD students working at KEMRI, UoN, or the MoH. We will also train 10 medium term non-degree scientists who have interest and potential in TB research will attend UW and take coursework in epidemiology and biostatistics or work in a laboratory for one to three months before returning to Kenya and engaging in a mentored research project. Finally, we will conduct short term workshops and provide on-line courses to build a critical mass of trained researchers who will create a supportive environment for research in TB. Together, these training opportunities will enhance local capacity and train the next generation of leaders who will discover novel research and public health strategies to combat the TB epidemic in Kenya.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas R Hawn其他文献

Thomas R Hawn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas R Hawn', 18)}}的其他基金

Development Core
开发核心
  • 批准号:
    10425947
  • 财政年份:
    2022
  • 资助金额:
    $ 28.69万
  • 项目类别:
Development Core
开发核心
  • 批准号:
    10595068
  • 财政年份:
    2022
  • 资助金额:
    $ 28.69万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10653901
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10271169
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:
Human macrophage variation & TB pathogenesis
人类巨噬细胞变异
  • 批准号:
    10459540
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:
Tuberculosis & HIV Co-Infection Training Program in Kenya
结核
  • 批准号:
    10392506
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:
Tuberculosis & HIV Co-Infection Training Program in Kenya
结核
  • 批准号:
    10239543
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10459535
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:
Human macrophage variation & TB pathogenesis
人类巨噬细胞变异
  • 批准号:
    10271173
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:
Human macrophage variation & TB pathogenesis
人类巨噬细胞变异
  • 批准号:
    10653916
  • 财政年份:
    2021
  • 资助金额:
    $ 28.69万
  • 项目类别:

相似国自然基金

猪源益生菌Bacillus licheniformis PGM584缓解仔猪断奶腹泻的机制研究
  • 批准号:
    2025JJ50141
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Bacillus subtilis 细胞传感器介导的肠道环境中结直肠癌相关生物标志物的动态检测策略
  • 批准号:
    82372355
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
枯草芽孢杆菌Bacillus subtilis T5高效制备纳米硒及其合成机制研究
  • 批准号:
    n/a
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
生物炭载解化感物质促生菌Bacillus cereus WL08缓解半夏连作障碍的机制研究
  • 批准号:
    32360023
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
工程化Bacillus clausii胞外囊泡口服递送PD-L1自阻断质粒协同抗胰腺癌作用研究
  • 批准号:
    82373277
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
CRISPR/CasΦ介导的Bacillus subtilis基因组精简重排进化与生理机制解析
  • 批准号:
    32300064
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
芽孢杆菌Bacillus sp.E044对羊肚菌主要病害-镰刀菌病生物防治的作用机制
  • 批准号:
    22ZR1442500
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Bacillus sp. DT2与凤眼莲根际生物膜对四环素的协同降解机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
基于Bacillus safensis的聚乳酸降解酶催化机制解析与分子改造
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
施用锰肥提高生防细菌Bacillus cereus 0-9在小麦根际定殖的作用机制
  • 批准号:
    32172488
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目

相似海外基金

Constitutive oxalate-biodegrading Bacillus subtilis for kidney stones
用于肾结石的组成型草酸盐生物降解枯草芽孢杆菌
  • 批准号:
    10740242
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Identifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
识别卡介苗 (BCG) 治疗的非肌层浸润性膀胱癌的新耐药机制
  • 批准号:
    10742368
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Chemical Biology of Nitroxyl (HNO) in Bacillus Subtilis
枯草芽孢杆菌中硝酰基 (HNO) 的化学生物学
  • 批准号:
    10730746
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Molecular Mechanisms of Y-Family Translesion Polymerase Activity in Bacillus subtilis
枯草芽孢杆菌 Y 家族跨损伤聚合酶活性的分子机制
  • 批准号:
    10730396
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Mechanisms and regulation of replication, the cell cycle, gene expression, and horizontal gene transfer in prokaryotes, focusing on Bacillus subtilis
原核生物复制、细胞周期、基因表达和水平基因转移的机制和调控,重点关注枯草芽孢杆菌
  • 批准号:
    10792219
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Discovery and functional analysis of novel selective cancer cell-damaging proteins produced by Bacillus thuringiensis.
苏云金芽孢杆菌产生的新型选择性癌细胞损伤蛋白的发现和功能分析。
  • 批准号:
    23K05020
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms and regulation of replication, the cell cycle, gene expression, and horizontal gene transfer in prokaryotes, focusing on Bacillus subtilis.
原核生物复制、细胞周期、基因表达和水平基因转移的机制和调控,重点关注枯草芽孢杆菌。
  • 批准号:
    10552390
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Interrogating laboratory-adapted strains of Bacillus subtilis to elucidate the selective pressures of laboratory conditions on multicellular bacterial behaviors
研究实验室适应的枯草芽孢杆菌菌株,以阐明实验室条件对多细胞细菌行为的选择压力
  • 批准号:
    10577916
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Bacillus Subtilis Chaperone/protease Mechanisms In Metabolic Shutdown
枯草芽孢杆菌伴侣/蛋白酶代谢关闭机制
  • 批准号:
    BB/X001415/1
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
    Research Grant
Development of a novel anthrax vaccine utilizing capsule biosynthesis protein CapA of Bacillus anthracis
利用炭疽杆菌荚膜生物合成蛋白CapA开发新型炭疽疫苗
  • 批准号:
    23K19460
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了